GLP-1 and GIP are both incretin hormones which are hormones that are released after eating
The longevity reframing is editorial position dressed up as data
If the product is vague, uses only marketing language, or cannot show a matching COA, choose the defined compound instead
Amycretin (NNC0487-0111) Novo Nordisk is currently conducting phase 1 clinical trials (NCT05369390, NCT06049329 and NCT06064006) to evaluate amycretin (NNC0487-0111), an oral and/or SC formulation combining GLP-1 RA and amylin peptides [126]
Sermorelin is well-documented for its safety and effectiveness, and has been used for decades to treat growth hormone deficiencies in both children and adults
They also delay aging , reduce free radical damage, and increase overall vitality